Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Inbunden, Engelska, 2020

1 459 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This book explores potential cellular drug targets for cancer therapy. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment.

Produktinformation

Utgivningsdatum2020-10-01
Mått155 x 235 x 18 mm
Vikt580 g
FormatInbunden
SpråkEngelska
Antal sidor228
FörlagSpringer Verlag, Singapore
ISBN9789811575853

Tillhör följande kategorier

Onkologi inom Medicin
Cellbiologi inom Naturvetenskap och teknik

Dr. Hardeep Singh Tuli is an Assistant Professor at the Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana Ambala. He previously served as a Lecturer at the Department of Applied Sciences, Institute of Science and Technology, Klawad, Yamunanagar (2009-2011), India. His research interests are focused on the isolation, characterization and biochemical evaluation of natural metabolites as anticancer agents. He has served as a reviewer for several international journals, and as a guest editor for the journal Frontiers in Pharmacology. He has more than 9 years of teaching and research experience in pharmacology, mammalian physiology, and natural products. He has published more than 70 papers in peer-reviewed international journals and authored a number of book chapters. In addition, Dr. Tuli is editorial board member of various national and international scientific research journals.

Chapter 1. History of oncotherapies in cancer biology.- Chapter 2. Electrochemical Sensors and Biosensors for the Detection of Cancer Biomarkers and Drugs.- Chapter 3. Cell cycle arrest: An impending therapeutic strategy to curb cancer.- Chapter 4. Apoptotic cell death: important cellular process as chemotherapeutic target.- Chapter 5. Regulatory roles of autophagy in cancer.- Chapter 6. ROS and Oxidative Stress in Cancer: Recent Advances.- Chapter 7. Inflammatory mediators: Potential drug targets in cancer.- Chapter 8. Pharmacologic modulation of the immune response against tumours in the elderly. Chapter 9. Angiogenesis: A Therapeutic Target for Cancer.- Chapter 10. Metastasis: A major driver of cancer pathogenesis.- Chapter 11. Designing Personalized and Innovative Novel Drug Therapies For Cancer Treatment.